237 filings
Page 11 of 12
10-K
4nfaf5ev
18 Mar 15
Annual report
12:00am
S-8
9pqiz v2g
18 Mar 15
Registration of securities for employees
12:00am
8-K
iyoot7pyvysckv
18 Mar 15
Nevro Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
8-K
1obnhzor gk3mq
9 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
1ypjhxf304nuai7sli
2 Mar 15
Nevro Appoints Dr. Brad Vale to its Board of Directors
12:00am
8-K
rlqywb
23 Jan 15
Nevro Receives Approvable Letter from U.S. Food and Drug Administration for Senza® Spinal Cord Stimulation System
12:00am
10-Q
972coo z2b
2 Dec 14
Quarterly report
12:00am
8-K
xbq3hs3coiskfd5
2 Dec 14
Nevro Reports Third Quarter Financial Results
12:00am
S-8
dorm9kj1529f kwqv
12 Nov 14
Registration of securities for employees
12:00am
8-K
pn4hj fpentj
12 Nov 14
Nevro Corp. Announces Full Exercise of Over-Allotment Option and Closing of Initial Public Offering
12:00am
CT ORDER
37we8t 78tm7c
6 Nov 14
Confidential treatment order
12:00am
FWP
lisausdm6 j668x3
6 Nov 14
Free writing prospectus
12:00am
424B4
enbiwg02bqxr4 uu
6 Nov 14
Prospectus supplement with pricing info
12:00am
EFFECT
w8tobdy7k64r7u1tglq
5 Nov 14
Notice of effectiveness
12:00am
S-1MEF
41ax18dn6qwnfjj
5 Nov 14
Registration of additional securities for an S-1
12:00am
CORRESP
gxkbowafqkvzlho6bq
3 Nov 14
Correspondence with SEC
12:00am
CORRESP
lvs5u1px 9wez17
3 Nov 14
Correspondence with SEC
12:00am
CERTNYS
vmhve9cjtz4v6u6sw
31 Oct 14
Certification of approval for NYSE listing
12:00am
8-A12B
1rbi5s89teum wtn
30 Oct 14
Registration of securities on exchange
12:00am